| Title : Meta-analysis of the cardiovascular outcomes with dipeptidyl peptidase 4 inhibitors: validation of the current FDA mandate - Agarwal_2014_Am.J.Cardiovasc.Drugs_14_191 |
| Author(s) : Agarwal S , Parashar A , Menon V |
| Ref : Am J Cardiovasc Drugs , 14 :191 , 2014 |
| Abstract : |
| PubMedSearch : Agarwal_2014_Am.J.Cardiovasc.Drugs_14_191 |
| PubMedID: 24687214 |
| Title : Meta-analysis of the cardiovascular outcomes with dipeptidyl peptidase 4 inhibitors: validation of the current FDA mandate - Agarwal_2014_Am.J.Cardiovasc.Drugs_14_191 |
| Author(s) : Agarwal S , Parashar A , Menon V |
| Ref : Am J Cardiovasc Drugs , 14 :191 , 2014 |
| Abstract : |
| PubMedSearch : Agarwal_2014_Am.J.Cardiovasc.Drugs_14_191 |
| PubMedID: 24687214 |
| Title : Meta-analysis of the cardiovascular outcomes with dipeptidyl peptidase 4 inhibitors: validation of the current FDA mandate - Agarwal_2014_Am.J.Cardiovasc.Drugs_14_191 |
| Author(s) : Agarwal S , Parashar A , Menon V |
| Ref : Am J Cardiovasc Drugs , 14 :191 , 2014 |
| Abstract : |
| PubMedSearch : Agarwal_2014_Am.J.Cardiovasc.Drugs_14_191 |
| PubMedID: 24687214 |